Back to Capital Research Global Investors

ABT
Showing 8 of 30 quarters

Position history for Capital Research Global Investors's holdings in ABBOTT LABORATORIES

Capital Research Global Investors holds 49.8M shares of ABT (ABBOTT LABORATORIES), worth $5.1B as of 2026-Q1. The position was increased (+27.1% shares). ABT represents 0.8% of Capital Research Global Investors's portfolio.

Current Value

$5.1B

Current Shares

49.8M

Total Value Change

-$837.3M

Total Shares Change

-7.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
49.8M
+27.1%
$5.1B0.8%$113.61
56
2025-Q4
Increased
39.2M
+1.0%
$4.9B0.9%$125.15
45
2025-Q3
Decreased
38.8M
-7.2%
$5.2B1.0%$131.85
0
2025-Q2
Decreased
41.8M
-17.7%
$5.7B1.1%$132.52
0
2025-Q1
Decreased
50.7M
-6.2%
$6.7B1.5%$128.41
0
2024-Q4
Increased
54.1M
+1.5%
$6.1B1.3%$110.14
51
2024-Q3
Decreased
53.3M
-6.9%
$6.1B1.3%$109.27
0
2024-Q2
Decreased
57.2M
-31.9%
$5.9B1.3%$100.45
0

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used